BNP Paribas Discount Zert MRNA 27.../ DE000PN53VP9 /
2024-06-05 8:00:31 PM | Chg.+0.12 | Bid8:20:17 PM | Ask8:20:17 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
73.38EUR | +0.16% | 73.36 Bid Size: 5,400 |
73.41 Ask Size: 5,400 |
Moderna Inc | - USD | 2024-06-27 | Call |
GlobeNewswire
05-22
Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
GlobeNewswire
05-12
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire
05-08
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
05-08
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
05-02
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-01
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
GlobeNewswire
05-01
CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire
04-04
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...